Finally, our research work is published in @NAR_Cancer_EIC
DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer https://t.co/mHy9tJUizH
Published: My recent research on PARP inhibitors in BRCA1/2-proficient cancers, featured in ACS Chemical Biology journal. #cancerresearch#dnadamage@ACSPublications Publications |https://t.co/odMk7QRqop
I’ve finally successfully defended my PhD thesis and am now stepping into the next phase of my journey👨🎓🙂. I am grateful to everyone who has been a part of my journey🙏🙏. @csir_iicb@AcSIR_India Institute: CSIR-Indian Institute of Chemical Biology, Kolkata
Achyut Bora (Registration No. 10BB19A17002) Ph.D. student of AcSIR will defend thesis entitled “Elucidating the therapeutic opportunities in DNA abasic sites and repair pathways in cancer cells” on January 03, 2025 at CSIR- Central Glass and Ceramic Research Institute, Kolkata Ph.D work was completed under the supervision of Dr.Sanjay Dutta, Associate Professor , AcSIR/CSIR-CGCRI, Kolkata @CSIR_IND@official_cgcri
🔬 New Research Alert! 🌟 Liposomal delivery of Annona muricata leaves extract for the treatment of hepatocellular carcinoma 🌟
Published in #DDIPJournal
📖Read the full article here: https://t.co/AVDQTjWdws
Metal-free internal nucleophile-triggered domino route for synthesis o... https://t.co/WMxSqeFIjn
Published a collaborative research study in Bioorganic Chemistry demonstrating DNA binding properties of diazepine hybrid small molecules and their potential anticancer activities.
@NAR_Cancer_EIC @NAR_Open The research introduces a compelling strategy to guide the development of potent and selective small molecules that target DNA abasic sites and their impact on repair via the BER (Base Excision Repair) pathway. #smallmolecules#DNA_Repair@SanjayD77430987 @CSM_Sci
Finally, our research work is published in @NAR_Cancer_EIC
DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer https://t.co/mHy9tJUizH